Lab-Grown immune organoids could unlock secrets of Kids' cancers

NCT ID NCT05890781

Recruiting now Knowledge-focused Sponsor: Gustave Roussy, Cancer Campus, Grand Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to create immune organoids—tiny lab-grown models of the immune system—using cells from children and young adults with brain tumors, kidney tumors, neuroblastoma, or sarcoma. Researchers will mix these organoids with tumor cells to see how they interact. The goal is to better understand these cancers, not to treat them directly. About 108 participants will provide tissue samples for this research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm kidney neoplasm neuroblastoma renal cell carcinoma sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN TUMOR KIDNEY TUMOR NEUROBLASTOMA SARCOMA

Contacts and locations

Locations

Gustave Roussy
RECRUITING

Villejuif, 94805, France
Hopital Necker
RECRUITING

Paris, Île-de-France Region, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.